Myriad Genetics (NASDAQ:MYGN) executives highlighted fourth quarter and full-year 2025 results alongside a slate of planned ...

The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would work — without requiring a clinical trial first.

Many law enforcement agencies are relying on crowdfunding to pay for genetic genealogy, which has helped solve hundreds of ...

In 2013, farmers in the highlands of Ethiopia began to notice something unsettling: a familiar variety of wheat was failing ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...